Blood Pressure: New Evidence New Targets

Katy Bell, Loai Albarqouni, Jenny Doust

Research output: Contribution to journalEditorialResearchpeer-review


Raised blood pressure, along with smoking and raised cholesterol levels, is a key
modifiable risk factor for cardiovascular (CV) disease in people with diabetes. “Hypertension” is in fact not a clinical disease in itself, in that individuals with raised blood pressure do not generally have symptoms, but rather have a risk factor for CV disease. There is no discrete boundary that defines the hypertensive state from the non-hypertensive one, and judgment is required to determine the diagnostic threshold (if one is used) and to determine target BP levels for treatment. Clinical guidelines have progressively lowered the threshold for diagnosing “hypertension” in both people with and without diabetes, from the 1970s definition of having a systolic blood pressure (SBP) of 160mmHg or diastolic blood pressure (DBP) of 95mmHg, to a SBP of 140mmHg or DBP of 90mmHg.
Original languageEnglish
Pages (from-to)24-27
Number of pages3
JournalDiabetes Management Journal
VolumeMay 2019
Publication statusPublished - May 2019


Dive into the research topics of 'Blood Pressure: New Evidence New Targets'. Together they form a unique fingerprint.

Cite this